SEARCH

SEARCH BY CITATION

References

  • 1
    Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med 1992; 37: 24973.
  • 2
    Linares CL, Pelletier AL, Czernichow S et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008; 37: 138.
  • 3
    Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo C-II deficiency and hepatic lipase deficiency. In: Scriver CR, Beaudet BL, Sly WS, Valle D, eds. The Metabolic & Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001; 2789.
  • 4
    Calandra S, Oliva CP, Tarugi P, Bertolini S. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr Opin Lipidol 2006; 17: 1227.
  • 5
    Oliva CP, Pisciotta L, Volti GL et al. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2005; 25: 4117.
  • 6
    Davies B, Beigneux A, Barnes Rn et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab 2010; 12: 4252.
  • 7
    Wang J, Hegele RA. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis 2007; 6: 23.
  • 8
    Beigneux AP, Franssen R, Bensadoun A et al. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 2009; 29: 95662.
  • 9
    Olivecrona G, Ehrenborg E, Semb H et al. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J Lipid Res 2010; 51: 153545.
  • 10
    Franssen R, Young SG, Peelman F et al. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet 2010; 3: 16976.
  • 11
    Coca-Prieto I, Valdivielso P, Olivecrona G et al. Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis. BMC Gastroenterol 2009; 9: 46.
  • 12
    Rahalkar AR, Giffen F, Har B et al. Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review. Can J Physiol Pharmacol 2009; 87: 15160.
  • 13
    Beigneux AP, Davies BS, Gin P et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 2007; 5: 27991.
  • 14
    Gin P, Beigneux AP, Davies B et al. Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution. Biochim Biophys Acta 2007; 1771: 14648.
  • 15
    Dallinga-Thie GM, Franssen R, Mooij HL et al. The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 2010; 211: 18.
  • 16
    Gin P, Beigneux AP, Voss C et al. Binding preferences for glycosylphosphatidylinositol HBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells. Arterioscler Thromb Vasc Biol 2011; 31: 17682.